Resilience Maine

Resilience Maine We provide physical therapy services in your home, our clinic, or with telerehabilitation.

Falling is not a normal part of aging. Give yourself a quick check or forward to a loved one:
09/15/2022

Falling is not a normal part of aging. Give yourself a quick check or forward to a loved one:

According to the U.S. Centers for Disease Control and Prevention, one-fourth of Americans aged 65+ falls each year. Answer a few quick questions to assess your risk of falling and get a personalized report to share with your health care provider.

06/06/2022

Patients with multiple sclerosis often experience a worsening of symptoms in warmer weather. This worsening, brought on by heat and/or humidity is temporary but should be avoided, when possible. Even short periods of overheating can result in worsening of symptoms.

05/21/2022

Are you prepared for this weekend's heat? Many people with MS experience temporary worsening of symptoms when the weather is very hot. A few strategies for easing the effects of heat: stay in air-conditioning, use cooling products, drink cold fluids and wear lightweight clothing.
Our next blog and Facebook Live topic in early June will cover outdoor activities and managing the heat.
In the meantime, additional information about heat & MS can be found at https://www.nationalmssociety.org/Living-Well-With-MS/Diet-Exercise-Healthy-Behaviors/Heat-Temperature-Sensitivity

Very important considerations. Patients who have Medicare do not need to improve functionally if they need PT to maintai...
03/31/2022

Very important considerations. Patients who have Medicare do not need to improve functionally if they need PT to maintain their function as long as it is skilled and medically necessary. We must advocate to ensure our patients receive the care they deserve.

If you receive physical or other therapy services through a nursing home or home health agency, you should know your rights. You also should know about changes to how Medicare pays for these services.

Getting closer.
01/16/2022

Getting closer.

Very interesting study! We always knew Epstein-Barr virus was an important risk factor for MS. Now it appears it may actually directly cause MS! What does this mean? Perhaps this could lead to more targeted treatments and prevention!

11/20/2021

Leaders - I want to hear from you. How do you make sure to put your team first? What results do you see from those efforts?

Taking the time to listen to our patients is the only way to get there.
10/03/2021

Taking the time to listen to our patients is the only way to get there.

Our choice of words can influence whether or not our friends and neighbors opt for the life-saving measure.

Fewer than 10% of PTs have this designation. Excellence in practice.
03/29/2021

Fewer than 10% of PTs have this designation. Excellence in practice.

Board certification is an important milestone for physical therapists looking to be lifelong learners and leaders in physical therapy. Sitting for the test can be difficult and uncertain, but it doesn’t have to be. You can choose a path that provides advanced training and prepares you for board ce...

Latest updates.
02/24/2021

Latest updates.

The Elliot Lewis Center will be providing information about the COVID-19 vaccines and MS. Updates will be posted to our website and page. Check back for additional updates. https://elliotlewisms.com/coronavirus

COVID-19 UPDATE AS OF 2/22/21

Are the vaccines safe?
YES! There are 2 vaccines approved for coronavirus, Pfizer and Moderna. These are mRNA vaccines that require 2 doses and are between 90-95% effective in preventing COVID-19. mRNA vaccines are felt to be safe for people with MS, regardless of what type of disease modifying therapy you are taking.

At this time, we are recommending that all our patients with MS get vaccinated with either the Pfizer or Moderna vaccines when they are available.

What about the other vaccines that may be released soon?
AstraZenica and Janssen (Johnson & Johnson) both have vaccines that may be released soon. These are a different technology than the current vaccines (viral vector vaccines). While these may be safe for patients with MS on medication, we are not making any specific recommendations until we have more information about these vaccines.

Do I qualify to get the vaccine?
The current plan in Massachusetts is to vaccinate people in 3 phases. Right now, we are in Phase 2: eligible groups include people who are 65 and older and/or those with 2 comorbid medical conditions. MS is not listed as a medical condition or “comorbidity” that qualifies you for phase 2. For a list of qualifying comorbidities, see Mass.gov). While Gilenya, Mayzent, Zepozia, Mavenclad, Ocrevus, Rituxan, Lemtrada, and Kesimpta all increase your risk of medications slightly, they are not currently considered to be comorbidities that qualify you for the vaccine.

Where do I get the vaccine?
The Mass.gov website has information on locations offering the vaccine for those who are eligible. See map for locations. Unfortunately, the Elliot Lewis Center will not be able to administer the vaccine.

Will I need a letter to document my diagnosis and/or treatment?
Thus far, doctors’ notes have not been required. We are not writing vaccine letters for patients at this time.

Will my MS medication interfere with the vaccine?
If you are on Ocrevus, Rituxan, or Kesimpta:
These medications reduce your B-lymphocytes (which create antibodies to fight infections) and may reduce your response to vaccines. Ocrevus was studied with the flu vaccine, and people developed a protective antibody response, though it was somewhat reduced. While we don’t know for sure, it seems very likely that since the coronavirus vaccines are 90-95% effective, they should provide some level of protection for patients on Ocrevus/Rituxan/Kesimpta.

It is not known if the timing of your infusion impacts the efficacy of vaccines. We are suggesting that you wait at least 2 weeks after your infusion of Rituxan or Ocrevus before getting vaccinated (if feasible). However, if you are offered the vaccine, our recommendation for most patients is to take the vaccine when it is available, rather than wait. If you have already been vaccinated, we recommend waiting at least 2 weeks after the second vaccine before getting your infusion. Please let us know when you have a specific date set for your vaccination, and we will advise you of any change of timing of your infusion.

If you are on Gilenya, Zeposia, or Mayzent:
It is possible that these medications may reduce the effectiveness of vaccines, but we still recommend that our patients be vaccinated. We do not recommend stopping these medications prior to being vaccinated because of the risk of relapse.

If you are on Mavenclad:
Mavenclad temporarily reduces your lymphocyte count for several months after a dose, though it is unclear if this reduces the effect of vaccines. We will decide the timing of vaccination on a case-by-case basis.

If you are on Aubagio, Tecfidera (or a fumarate drug), Tysabri, interferon, or glatiramer:
These medications are not known to interfere with vaccines and coronavirus vaccines should be effective.

Address

23 Hannaford Drive
Scarborough, ME
04074

Alerts

Be the first to know and let us send you an email when Resilience Maine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Resilience Maine:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram